News

Collaboration will enable clinical trials as a care alternative for more people and empower greater diversity among research participants.

PPMI is designed to identify biological markers and clinical changes associated with Parkinson's disease risk, onset, and progression.

New survey will assess how pharma and biotech companies are incorporating patient engagement into their drug development organizations and operations.

Digital twins, defined as a typical demographic patient profile in a specific population, have the potential to help clinical trial design.

Updated CTMS streamlines trial management to speed medicines to patients.

Partnership to recognize volunteers who participate in clinical trials.

Initiative to help share more clinical research opportunities.

Acquisition to accelerate enrollment, improve diversity, and enhance patient experience in DCTs.

Brings Brazilian total to 22 hospitals and over 8 million patients.

The latest business and people news from the past month, all in one place.

New site provides comprehensive overview of clinical trials.

Industry experts agree that patient centricity should be overriding aim of global life science R&D and healthcare ecosystems.

Available on Salesforce AppExchange, SeqsterOS will empower life sciences companies to integrate RWD and EHRs.

Porter discusses regulatory compliance, ATMP sponsors, and Philadelphia’s Cellicon Valley.

New initiative to be named Robert A. Winn Diversity in Clinical Trials Award Program.

Expansion of services to meet increasing demand from industry.

New partnership brings AiCure solutions to Italy.

WCG's suite of clinical trial solutions will be made available to a wider range of CROs.

Neurology model will help power real-world evidence generation into the rare-disease patient journey.

Newly combined organization to provide pharmacovigilance solution focused on current and future requirements of the life sciences industry.

Specialty area to focus on major depression, schizophrenia, multiple sclerosis, and more.

Regulatory bodies in Europe offer guidance for sponsors in light of recent events.

Organizations will decentralize patient assessments in preclinical Alzheimer’s disease research.

With Veeva Development Cloud, Boehringer Ingelheim aims to accelerate the development of novel medicines.

New monitoring and recording technology will further compliment existing library of DCT, ePRO tools.

Collaboration on new AI-driven technology will enhance THREAD's existing platform.

Will bridge critical gaps in care for people of color with moderate to severe plaque psoriasis.

Data demonstrates efficacy of smart dosing technology.